Style | Citing Format |
---|---|
MLA | Rastegarpouyani N, et al.. "The Impact of Cancer-Associated Fibroblasts on Drug Resistance, Stemness, and Epithelial-Mesenchymal Transition in Bladder Cancer: A Comparison Between Recurrent and Non-Recurrent Patient-Derived Cafs." Cancer Investigation, vol. 41, no. 7, 2023, pp. 656-671. |
APA | Rastegarpouyani N, Montazeri V, Marandi N, Aliebrahimi S, Andalib M, Jafarzadeh E, Montazeri H, Ostad SN (2023). The Impact of Cancer-Associated Fibroblasts on Drug Resistance, Stemness, and Epithelial-Mesenchymal Transition in Bladder Cancer: A Comparison Between Recurrent and Non-Recurrent Patient-Derived Cafs. Cancer Investigation, 41(7), 656-671. |
Chicago | Rastegarpouyani N, Montazeri V, Marandi N, Aliebrahimi S, Andalib M, Jafarzadeh E, Montazeri H, Ostad SN. "The Impact of Cancer-Associated Fibroblasts on Drug Resistance, Stemness, and Epithelial-Mesenchymal Transition in Bladder Cancer: A Comparison Between Recurrent and Non-Recurrent Patient-Derived Cafs." Cancer Investigation 41, no. 7 (2023): 656-671. |
Harvard | Rastegarpouyani N et al. (2023) 'The Impact of Cancer-Associated Fibroblasts on Drug Resistance, Stemness, and Epithelial-Mesenchymal Transition in Bladder Cancer: A Comparison Between Recurrent and Non-Recurrent Patient-Derived Cafs', Cancer Investigation, 41(7), pp. 656-671. |
Vancouver | Rastegarpouyani N, Montazeri V, Marandi N, Aliebrahimi S, Andalib M, Jafarzadeh E, et al.. The Impact of Cancer-Associated Fibroblasts on Drug Resistance, Stemness, and Epithelial-Mesenchymal Transition in Bladder Cancer: A Comparison Between Recurrent and Non-Recurrent Patient-Derived Cafs. Cancer Investigation. 2023;41(7):656-671. |
BibTex | @article{ author = {Rastegarpouyani N and Montazeri V and Marandi N and Aliebrahimi S and Andalib M and Jafarzadeh E and Montazeri H and Ostad SN}, title = {The Impact of Cancer-Associated Fibroblasts on Drug Resistance, Stemness, and Epithelial-Mesenchymal Transition in Bladder Cancer: A Comparison Between Recurrent and Non-Recurrent Patient-Derived Cafs}, journal = {Cancer Investigation}, volume = {41}, number = {7}, pages = {656-671}, year = {2023} } |
RIS | TY - JOUR AU - Rastegarpouyani N AU - Montazeri V AU - Marandi N AU - Aliebrahimi S AU - Andalib M AU - Jafarzadeh E AU - Montazeri H AU - Ostad SN TI - The Impact of Cancer-Associated Fibroblasts on Drug Resistance, Stemness, and Epithelial-Mesenchymal Transition in Bladder Cancer: A Comparison Between Recurrent and Non-Recurrent Patient-Derived Cafs JO - Cancer Investigation VL - 41 IS - 7 SP - 656 EP - 671 PY - 2023 ER - |